title: [A case of complete response in a patient with invasive bladder cancer due to intermittent intraarterial infusion chemotherapy using the alteration of blood flow].
abstract: The patient was a 70-year-old male with invasive bladder cancer. We performed intermittent arterial infusion (ITI) combined with alteration of blood flow in the bladder wall using the contralateral arterial embolization. As for anti-tumor agents, cisplatin (CDDP) 10mg and pirarubic in (THP) 10 mg were selected, and were injected every week for 11 times. Complete response (CR) was noted by cystoscopy and biopsied specimen. In our conclusion. ITI was useful for the treatment of bladder cancer.
authors.affiliation: Department of Urology, Osaka City University Medical School.
authors.forename: H
authors.initials: H
authors.lastname: Minami
authors.forename: M
authors.initials: M
authors.lastname: Umeda
authors.forename: T
authors.initials: T
authors.lastname: Maekawa
authors.forename: H
authors.initials: H
authors.lastname: Yoshihara
authors.forename: T
authors.initials: T
authors.lastname: Nakatani
authors.forename: R
authors.initials: R
authors.lastname: Yasumoto
authors.forename: T
authors.initials: T
authors.lastname: Kishimoto
mesh_terms: D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage*; D016461:Chemoembolization, Therapeutic; D002945:Cisplatin / Q000008:administration & dosage; D004317:Doxorubicin / Q000008:administration & dosage / Q000031:analogs & derivatives; D004334:Drug Administration Schedule; D006801:Humans; D015918:Infusion Pumps, Implantable; D007261:Infusions, Intra-Arterial; D008297:Male; D009361:Neoplasm Invasiveness; D012039:Regional Blood Flow; D012074:Remission Induction; D001749:Urinary Bladder Neoplasms / Q000098:blood supply* / Q000188:drug therapy* / Q000473:pathology
chemical_list: D004317:Doxorubicin; C027260:pirarubicin; D002945:Cisplatin